Andrew McLaren

2.2k total citations
13 papers, 367 citations indexed

About

Andrew McLaren is a scholar working on Psychiatry and Mental health, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Andrew McLaren has authored 13 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Cardiology and Cardiovascular Medicine and 3 papers in Surgery. Recurrent topics in Andrew McLaren's work include Schizophrenia research and treatment (3 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Andrew McLaren is often cited by papers focused on Schizophrenia research and treatment (3 papers), Neurological Disease Mechanisms and Treatments (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Andrew McLaren collaborates with scholars based in United Kingdom and Australia. Andrew McLaren's co-authors include Clive Ballard, Rose Anne Kenny, Simon Kerr, Christopher M. Morris, David Duthie, John T. O’Brien, W.S. Nimmo, Ian G. McKeith, Alan Murray and David Copolov and has published in prestigious journals such as Stroke, Annals of the New York Academy of Sciences and The British Journal of Psychiatry.

In The Last Decade

Andrew McLaren

12 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew McLaren United Kingdom 9 115 101 78 69 68 13 367
RJ Dobbs United Kingdom 9 93 0.8× 71 0.7× 52 0.7× 154 2.2× 36 0.5× 16 401
Christopher W. May United States 15 128 1.1× 59 0.6× 160 2.1× 125 1.8× 75 1.1× 22 663
Carolyn M. Coyne United States 8 87 0.8× 158 1.6× 199 2.6× 46 0.7× 40 0.6× 11 396
V. Canonico Italy 9 300 2.6× 212 2.1× 128 1.6× 36 0.5× 41 0.6× 27 635
Kate V. Allen United Kingdom 6 60 0.5× 79 0.8× 123 1.6× 22 0.3× 99 1.5× 8 624
Y Loria France 8 65 0.6× 45 0.4× 51 0.7× 225 3.3× 55 0.8× 13 508
Frances Harrington United Kingdom 9 189 1.6× 154 1.5× 77 1.0× 22 0.3× 35 0.5× 12 585
Andrew J. Sommerfield United Kingdom 6 92 0.8× 52 0.5× 81 1.0× 17 0.2× 60 0.9× 10 437
Vladimir Jiménez Venezuela 9 90 0.8× 70 0.7× 122 1.6× 53 0.8× 33 0.5× 12 378
Gary W. Jay United States 10 53 0.5× 247 2.4× 91 1.2× 51 0.7× 65 1.0× 21 515

Countries citing papers authored by Andrew McLaren

Since Specialization
Citations

This map shows the geographic impact of Andrew McLaren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew McLaren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew McLaren more than expected).

Fields of papers citing papers by Andrew McLaren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew McLaren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew McLaren. The network helps show where Andrew McLaren may publish in the future.

Co-authorship network of co-authors of Andrew McLaren

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew McLaren. A scholar is included among the top collaborators of Andrew McLaren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew McLaren. Andrew McLaren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
McLaren, Andrew, Simon Kerr, Louise Allan, et al.. (2005). Autonomic Function Is Impaired in Elderly Stroke Survivors. Stroke. 36(5). 1026–1030. 82 indexed citations
2.
Newton, Julia L., Simon Kerr, Jessie Pairman, et al.. (2005). Familial neurocardiogenic (vasovagal) syncope. American Journal of Medical Genetics Part A. 133A(2). 176–179. 28 indexed citations
3.
Ballard, Clive, Sally Stephens, Andrew McLaren, Keith Wesnes, & Rose Anne Kenny. (2003). Mild Cognitive Impairment and Vascular Cognitive Impairment in Stroke Patients. International Psychogeriatrics. 15. 123–126. 11 indexed citations
4.
McKeith, Ian G., David J. Burn, Clive Ballard, et al.. (2003). Dementia with Lewy bodies. PubMed. 8(1). 46–57. 105 indexed citations
5.
Ballard, Clive, Sally Stephens, Andrew McLaren, et al.. (2002). Neuropsychological Deficits in Older Stroke Patients. Annals of the New York Academy of Sciences. 977(1). 179–182. 14 indexed citations
6.
McLaren, Andrew, et al.. (2001). How Reliable are Reported Plasma Clozapine Levels?. Australian & New Zealand Journal of Psychiatry. 35(4). 468–473. 3 indexed citations
7.
Ballard, Clive, Andrew McLaren, & Christopher M. Morris. (2000). Non-Alzheimer dementias. Current Opinion in Psychiatry. 13(4). 409–414.
8.
McLaren, Andrew, et al.. (1998). The Clinical Use of Plasma Clozapine Levels. Australian & New Zealand Journal of Psychiatry. 32(4). 567–574. 35 indexed citations
9.
McLaren, Andrew, et al.. (1998). The clinical use of plasma clozapine levels. Australian & New Zealand Journal of Psychiatry. 32(4). 567–574. 3 indexed citations
10.
Duthie, David, Andrew McLaren, & W.S. Nimmo. (1986). PHARMACOKINETICS OF FENTANYL DURING CONSTANT RATE I.V. INFUSION FOR THE RELIEF OF PAIN AFTER SURGERY. British Journal of Anaesthesia. 58(9). 950–956. 33 indexed citations
11.
McAreavey, Dorothea, Lenny Ramsey, L. P. Latham, et al.. (1984). "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.. BMJ. 288(6411). 106–111. 43 indexed citations
12.
McAreavey, Dorothea, A R Lorimer, James Reid, et al.. (1984). “Third drug” trial. BMJ. 288(6422). 1008.4–1009. 1 indexed citations
13.
Krasner, N, Michael Moore, A. Goldberg, et al.. (1976). A Trial of Fenfluramine in the Treatment of the Chronic Alcoholic Patient. The British Journal of Psychiatry. 128(4). 346–353. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026